New pill shows promise for Long-Term psoriatic arthritis control
NCT ID NCT07286058
First seen Jan 10, 2026 · Last updated May 10, 2026 · Updated 23 times
Summary
This study looks at the long-term safety and effectiveness of the drug zasocitinib for adults with psoriatic arthritis, a condition that causes joint pain and skin problems. Participants who completed a one-year study on this drug can join and will take zasocitinib daily for up to two more years. The goal is to see if the drug remains safe and helps control symptoms over time.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PSORIATIC ARTHRITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
First OC Dermatology Research Inc.
RECRUITINGFountain Valley, California, 92708, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.